The School of Public Health champions a commitment to equity and social justice and prioritizes its global approach to health education, scholarship, and community engagement. Many of Rutgers’ public health faculty are engaged in global health, given the myriad connections between the two fields.
As part of an NIH initiative, Rutgers researchers will provide serologic antibody testing to help determine the incidence and effects of long COVID on children. The testing will be performed in the laboratory of Maria Laura Gennaro, a core faculty member of Rutgers Global Health Institute.
The program, called Cancer Kitso, is being developed by the Botswana-Rutgers Partnership for Health to educate health care workers about cancer care and prevention. Pharmacists Joyce Kgatlwane and Jiyeon Joy Park discuss their involvement.
Refeletswe Lebelonyane is a physician, public health professional, and program manager for the Botswana-Rutgers Partnership for Health. In this Q&A, she provides updates on cancer care and prevention efforts in Botswana and reflects on her past experiences confronting HIV/AIDS in the African country.
School of Public Health researcher Kristen Krause, an instructor in the Department of Urban-Global Public Health, discusses FDA restrictions on who can and cannot donate blood and the impact for men who have sex with men, a population that is subject to such restrictions.
In an episode of the Bloomberg Balance of Power podcast titled “Responding to the Omicron Variant,” Rutgers Global Health Institute director Richard Marlink talks about vaccination uptake, protecting older people, mask mandates, frustrations with government officials, travel bans, and holiday gatherings.
A Rutgers Global Health Institute initiative combines advancements in telemedicine with lessons learned from earlier battles against HIV to increase cancer survival rates in an area that needs it the most.
While the overall rates of HIV/AIDS have decreased, the risk of infections within certain populations has surged. New Jersey Medical School faculty member Shobha Swaminathan is a clinical site leader for a vaccine trial that aims to provide HIV immunity for life.
The integration of cancer control into HIV settings in sub-Saharan Africa was the subject of Rutgers Global Health Institute director Richard Marlink’s presentation at the 23rd International AIDS Conference.
COVID-19 has reached many sub-Saharan African countries that are already suffering from malnutrition and disease, under-resourced health systems, and limited economic funding. Richard Marlink, director of Rutgers Global Health Institute and a leader in the global response to HIV/AIDS, discusses how this pandemic is likely to impact the African region and what can be done to help these countries.
